Proton Pump Inhibitors Concept

subject area of

• A 45-year experience with surgical treatment of peptic ulcer disease in children  Academic Article
• A Canadian Clinical Practice Algorithm for the Management of Patients with Non-Variceal Upper Gastrointestinal Bleeding  Academic Article
• A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Versus Proton Pump Inhibitors for Treatment of Patients With Chronic Gastroesophageal Reflux Disease: One-Year Follow-Up  Academic Article
• A comparison of 30-day versus 90-day proton pump inhibitor therapy in prevention of marginal ulcers after laparoscopic Roux-en-Y gastric bypass  Academic Article
• A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes  Academic Article
• ACG Clinical Guideline: Treatment of Helicobacter pylori Infection  Academic Article
• ACG and CAG Clinical Guideline: Management of Dyspepsia  Academic Article
• Acid-NSAID/Aspirin Interaction in Peptic Ulcer Disease  Academic Article
• An Update on Anti-Helicobacter Pylori Treatment in Children  Academic Article
• Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone  Academic Article
• Antisecretory Therapy for Bleeding Peptic Ulcer  Academic Article
• Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update  Academic Article
• Barrett's esophagus: proton pump inhibitors and chemoprevention II  Academic Article
• Canadian Association of Gastroenterology Position Statement: Hip Fracture and Proton Pump Inhibitor Therapy – a 2013 Update  Academic Article
• Canadian Helicobacter Study Group Consensus Conference: Update on the Management ofHelicobacter pylori- An Evidence-Based Evaluation of Six Topics Relevant to Clinical Outcomes in Patients Evaluated forH pyloriInfection  Academic Article
• Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis - results from the maintenance phase of the EXPO study  Academic Article
• Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis - results from the EXPO study  Academic Article
• Clopidogrel plus aspirin in atrial fibrillation.  Academic Article
• Commentary: what is the optimal PPI dosing following endoscopic haemostasis in acute ulcer bleeding?  Academic Article
• Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding  Academic Article
• Controversial issues in gastroesophageal reflux disease.  Academic Article
• Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn  Academic Article
• Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agents  Academic Article
• Counting the cost of proton pump inhibitors  Academic Article
• Current Guidelines on Stress Ulcer Prophylaxis  Academic Article
• Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint  Academic Article
• Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial  Academic Article
• Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID  Academic Article
• Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.  Academic Article
• Deprescribing versus continuation of chronic proton pump inhibitor use in adults  Academic Article
• Diagnostic and Therapeutic Use of Proton Pump Inhibitors in Non-Cardiac Chest Pain: A Metaanalysis  Academic Article
• Do patients with non-ulcer dyspepsia respond differently toHelicobacter pylorieradication treatments from those with peptic ulcer disease? A systematic review  Academic Article
• Dyspepsia  Academic Article
• Dyspepsia results may not apply in primary care  Academic Article
• Early Relief of Upper Gastrointestinal Dyspeptic Symptoms: A Survey of Empirical Therapy with Pantoprazole in Canadian Clinical Practice  Academic Article
• Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis  Academic Article
• Economic Reflections on Proton Pump Inhibitor Therapy for Non-Erosive Reflux Disease  Conference Paper
• Editor's Correspondence  Academic Article
• Editorial: How Much Do PPIs Contribute to C. difficile Infections?  Academic Article
• Editorial: PPIs and Recurrent C. difficile Infection: No Association?  Academic Article
• Editorial: Sequential Therapy for Eradication of Helicobacter pylori: A New Guiding Light or a False Dawn?  Academic Article
• Editorial: healing of refractory reflux oesophagitis - an ongoing unmet clinical need  Academic Article
• Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care  Academic Article
• Effect on Intragastric pH of a PPI with a Prolonged Plasma Half-Life: Comparison between Tenatoprazole and Esomeprazole on the Duration of Acid Suppression in Healthy Male Volunteers  Academic Article
• Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials  Academic Article
• Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection  Academic Article
• Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials  Academic Article
• Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability  Academic Article
• Eradication of Helicobacter pylori Infection  Academic Article
• Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study1  Academic Article
• Etiology of Dyspepsia: Implication for Empiric Therapy  Academic Article
• Evolving issues in the management of reflux disease?  Academic Article
• Explaining Divergent Results of Meta-Analyses on Proton Pump Inhibitor Treatment for Ulcer Bleeding  Academic Article
• Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Academic Article
• From Bench to Bedside to Bug: An Update of Clinically Relevant Advances in the Care of Persons withHelicobacter pyloriAssociated Diseases  Academic Article
• GORD in adults.  Academic Article
• Gastro-oesophageal reflux disease  Academic Article
• Gastro-oesophageal reflux disease.  Academic Article
• Gastro-oesophageal reflux disease.  Academic Article
• Gastro-oesophageal reflux disease.  Academic Article
• Gastroesophageal reflux disease  Academic Article
• Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care - the CADET-HR Study  Academic Article
• Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial)  Academic Article
• Helicobacter pylori: a clinical update  Academic Article
• Hip Fracture and Proton Pump Inhibitor Therapy: Balancing the Evidence for Benefit and Harm  Academic Article
• Hip Fracture and Proton Pump Inhibitor Therapy: Position Statement  Academic Article
• How Can the Current Strategies forHelicobacter pyloriEradication Therapy be Improved?  Academic Article
• Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis  Academic Article
• Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis  Academic Article
• Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia.  Academic Article
• International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding  Academic Article
• Intravenous proton pump inhibitor therapy: a rationale for use.  Academic Article
• Is it safe to use a proton pump inhibitor with clopidogrel?  Academic Article
• Latin American Consensus on Gastroesophageal Reflux Disease: An Update on Therapy  Academic Article
• Levofloxacin-Based Three-Antibiotic Regimen for H. pylori Eradication  Academic Article
• Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease  Academic Article
• Management of Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Disease by Acid Suppression  Academic Article
• Management of reflux esophagitis: does the choice of proton pump inhibitor matter?  Academic Article
• Management of reflux-related symptoms  Academic Article
• Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report  Academic Article
• Managing dyspepsia  Academic Article
• Managing uninvestigated dyspepsia in primary care  Academic Article
• Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease  Academic Article
• Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease  Academic Article
• Medical treatments in the short term management of reflux oesophagitis  Academic Article
• Medical treatments in the short term management of reflux oesophagitis  Academic Article
• Melena: a rare presentation of childhood Burkitt's lymphoma  Academic Article
• Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia  Academic Article
• Myocardial Infarction, Peptic Ulcer and Acetylsalicylic Acid: Of Good and Evil  Academic Article
• Myths and facts in the use of anti-inflammatory drugs  Academic Article
• New Pharmacologic Approaches in Gastroesophageal Reflux Disease  Academic Article
• New Pharmacologic Approaches in Gastroesophageal Reflux Disease  Academic Article
• Night-time intra-oesophageal bile and acid exposure in GERD patients failing PPI therapy  Academic Article
• Novel Pharmaceutical Approaches to Reflux Disease  Academic Article
• OVER THE FENCE  Academic Article
• Omeprazole--a new formulation.  Academic Article
• Optimum duration of regimens for Helicobacter pylori eradication  Academic Article
• PPI co-therapy did not adversely affect outcomes in clopidogrel users  Academic Article
• Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.  Academic Article
• Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia  Academic Article
• Post-operative management of esophageal atresia–tracheoesophageal fistula and gastroesophageal reflux: A Canadian Association of Pediatric Surgeons annual meeting survey  Academic Article
• Precise Role of Acid in Non-Erosive Reflux Disease  Academic Article
• Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z  Academic Article
• Predictors of clinical events occurring during hospital stay among elderly patients admitted to medical wards in Italy  Academic Article
• Predictors of treatment response in patients with non-erosive reflux disease  Academic Article
• Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients  Academic Article
• Prevention of anti‐inflammatory drug‐induced gastrointestinal damage: Benefits and risks of therapeutic strategies  Academic Article
• Progress with proton pump inhibition.  Academic Article
• Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery: a systematic review and meta-analysis of cohort studies  Academic Article
• Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients  Academic Article
• Proton Pump Inhibitor Therapy for Peptic Ulcer Bleeding: Cochrane Collaboration Meta-analysis of Randomized Controlled Trials  Academic Article
• Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis  Academic Article
• Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients  Academic Article
• Proton Pump Inhibitors and Clopidogrel – Hazardous Drug Interaction or Hazardous Interpretation of Data?  Academic Article
• Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study  Academic Article
• Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies  Academic Article
• Proton Pump Inhibitors and the Risk of Adverse Cardiac Events  Academic Article
• Proton pump inhibitor treatment for acute peptic ulcer bleeding  Academic Article
• Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding  Academic Article
• Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding  Academic Article
• Proton pump inhibitors and oesophageal cancer: Flawed methodology and false alarms  Academic Article
• Proton pump inhibitors for functional dyspepsia  Academic Article
• Proton pump inhibitors for functional dyspepsia  Academic Article
• Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.  Academic Article
• Proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding  Academic Article
• Proton pump inhibitors: the beginning of the end or the end of the beginning?  Academic Article
• Recent Safety Concerns With Proton Pump Inhibitors  Academic Article
• Response to "Potentially Flawed Interpretation of Data by Andriulli et al."  Academic Article
• Review article: current treatment options and management of functional dyspepsia  Academic Article
• Review article: gastric pH - the most relevant predictor of benefit in reflux disease?  Academic Article
• Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005  Academic Article
• Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection  Academic Article
• Sequential regimens for Helicobacter pylori eradication  Academic Article
• Sequential therapy - more studies are still required  Academic Article
• Should We Test for Helicobacter Pylori before Treating Gastroesophageal Reflux Disease?  Academic Article
• Should we step‑up or step‑down in the treatment of new‑onset dyspepsia in primary care?  Academic Article
• Stress Ulcer Prophylaxis  Academic Article
• Stress ulcer prophylaxis in critical illness: a Canadian survey  Academic Article
• Stress ulcer prophylaxis in critically ill patients: review of the evidence  Academic Article
• Surgical outcome in gastro-esophageal reflux disease patients with inadequate response to proton pump inhibitors  Academic Article
• Survey of current perspectives on laryngopharyngeal reflux among Canadian otolaryngologists.  Academic Article
• Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.  Academic Article
• Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression  Academic Article
• Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding  Academic Article
• Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia - a post hoc analysis from the Cochrane Collaboration  Academic Article
• Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay - results from the Cochrane Collaboration  Academic Article
• Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding  Academic Article
• The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting  Academic Article
• The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis  Academic Article
• The Esophageal and Gastric Microbiome in Health and Disease  Academic Article
• The Interaction Between Proton Pump Inhibitors and Clopidogrel and Upper Gastrointestinal Bleeding  Academic Article
• The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Bleeding  Academic Article
• The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving Forward to New Concepts  Academic Article
• The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults  Academic Article
• The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study  Academic Article
• The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis  Academic Article
• The impact of illness in patients with moderate to severe gastro-esophageal reflux disease  Academic Article
• The impact of intensifying acid suppression on sleep disturbance related to gastro-oesophageal reflux disease in primary care  Academic Article
• The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole  Academic Article
• The management of postoperative reflux in congenital esophageal atresia–tracheoesophageal fistula: a systematic review  Academic Article
• The methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia  Academic Article
• The pharmacodynamics and pharmacokinetics of S-tenatoprazole-Na 30 mg, 60 mg and 90 mg vs. esomeprazole 40 mg in healthy male subjects  Academic Article
• The rationale of acid suppression in the treatment of acid-related disease.  Academic Article
• The relationship between long-term proton pump inhibitor therapy and skeletal frailty  Academic Article
• The risks of PPI therapy  Academic Article
• To Establish the Efficacy of PPI Therapy for Ulcer Bleeding in the United States, Do We Need More Patients or More PPIs?  Academic Article
• Treatment of chronic gastro-oesophageal reflux disease  Academic Article
• Trials on stress ulcer prophylaxis: finding the balance between benefit and harm. Response to Krag et al.  Academic Article
• Validation of a Short Questionnaire in English and French for Use in Patients with Persistent Upper Gastrointestinal Symptoms Despite Proton Pump Inhibitor Therapy: The Pass (Proton Pump Inhibitor Acid Suppression Symptom) Test  Academic Article
• What about the role of sulfasalazine?  Academic Article
• Whistler Summary: ???The Slow Rate of Rapid Progress???  Academic Article
• Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients  Academic Article